Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Duke Research for Collaboration Enhancement in Clinical & Translational Science (Re-ConneCTS) Award Program (2026 2028)

Duke University

The Duke Clinical and Translational Science Institute (CTSI) invites applications to the Research for Collaboration Enhancement in Clinical & Translational Science (Re-ConneCTS) Award Program, which supports research to improve the functioning and performance of collaborations within clinical and translational research. The program seeks practical, innovative, generalizable, and scalable approaches to strengthening collaboration across the translational research spectrum. The award will provide up to $125,000 per year in direct costs for a project period of up to two years.

Effective collaboration is essential to impactful clinical and translational research, yet persistent challenges—like misaligned incentives and timelines, power and resource asymmetries, unclear roles and governance, and barriers related to communication and trust—continue to create obstacles to forming, operating, and sustaining productive teams, particularly for academic–community and cross-institutional partnerships, including those between academic medical centers and minority-serving institutions. Addressing these barriers is critical to accelerating the translation of discoveries into improved health outcomes.

By supporting research that systematically examines and strengthens collaborative processes, the Re-ConneCTS Award Program aligns with NCATS CTSA Program goals and advances Duke CTSI priorities to improve efficiency, effectiveness, and impact of translational research; accelerate translation; and build sustainable, high-functioning partnerships across disciplines, institutions, and communities.

We encourage applications that propose to design and evaluate evidence-based, rigorous interventions to enhance collaboration at any scale—within teams, across departments, between institutions, or with community partners. This funding supports projects that test innovative approaches or adapt and implement existing, proven strategies to improve collaboration in clinical and translational research.

Deadline: June 1, 2026

Specialties

Interdisciplinary

Medical - Clinical Science

Medical

Medical - Translational

Eligibility Requirements

Eligible applicants include faculty and non-faculty investigators at Duke University, North Carolina Central University (NCCU), or Duke CTSA collaborator/partner organizations, with demonstrated capacity to lead independent research.
Multiple PI (MPI) proposals are allowed. The distinct role and responsibilities of each PI must be made clear. One PI must be designated the contact PI.
Applicants must have a PI status per their organization’s policy.
- View Duke’s written policy
- View NCCU’s written policy
- For further questions regarding eligibility, contact the Program Award Team at ctsifunding@duke.edu using subject line “Re-ConneCTS Award: [Contact PI Last Name]”
Inter-institutional collaborations are strongly encouraged, with the understanding that investigators will share responsibility for the conduct and direction of the project.
More than one proposal may be submitted with an applicant acting as PI or co-PI.
PIs will be required to attest that all key personnel have a) contributed to the development of the application and b) given explicit permission for their inclusion.

Sponsor Details

Sponsor Institute/Organizations: Duke University

Sponsor Type:

Address: 103 Allen Bldg, Durham, NC 27708

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity